Marc and Jennifer Lipschultz Precision Immunology Institute

Icahn School of Medicine at Mount Sinai

97 Active
278 Finished

Mechanistic modeling of epigenetic modifier mutations in human pluripotent stem cell-derived immune cells
Byun, M.
National Institute of Allergy and Infectious Diseases
1/02/22 → 31/01/23
Project: Research
Evolution of cortical pathology and its relation to meningeal inflammation in multiple sclerosis
Beck, E.
National Multiple Sclerosis Society
20/09/21 → 19/09/24
Project: Research
Experimental and natural SARS-CoV-2 infection of the human pancreas
Homann, D., Schotsaert, M., Schotsaert, M. M. & Schotsaert, M.
National Institute of Diabetes and Digestive and Kidney Diseases
17/09/21 → 31/08/23
Project: Research
Advancing CAR T cell therapy for solid tumors
Ahmed, J. J. & Ahmed, J.
NIH Office of the Director
14/09/21 → 31/08/23
Project: Research
Skin Biology and Diseases Resource-based Center at Mount Sinai
Ezhkova, E., Bowcock, A., Guccione, E., Rendl, M., Guccione, E. E., Guccione, E., Rendl, M. M. & Rendl, M.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
1/09/21 → 31/08/23
Project: Research
FUNCTIONAL CHARACTERIZATION OF THE PRDM10-ZN FINGER TRANSCRIPTION FACTOR IN EARLY MAMMALIAN DEVELOPMENT
Guccione, E. & Guccione, E.
National Institute of Child Health and Human Development
31/08/21 → 30/04/23
Project: Research
Genomics Core
Raj, T. & Raj, T. T.
National Institute of Neurological Disorders and Stroke
15/08/21 → 31/08/23
Project: Research
Modeling HIV Microglia-Associated Infection and Inflammation in a Chimeric Mouse Brain
Akbarian, S., Chen, B., Swartz, T., Chen, B. K., Swartz, T. H. & Swartz, T. T. H.
National Institute on Drug Abuse
1/08/21 → 31/05/23
Project: Research
Resource Core D - Bioinformatics and Statistical Analysis Core
Guccione, E. & Guccione, E. E.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
1/07/21 → 31/08/23
Project: Research
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS
Dar, A., Guccione, E., Lujambio, A., Guccione, E. E., Guccione, E. & Lujambio, A.
National Cancer Institute
1/07/21 → 30/06/23
Project: Research
Altered inflammatory response associated with acquired DNMT3A mutations
Byun, M. & Byun, M.
National Heart, Lung, and Blood Institute
1/05/21 → 30/04/23
Project: Research
Single cell transcriptomics of HIV persistence and latency
Chen, B. B. K. & Chen, B.
National Institute of Allergy and Infectious Diseases
19/03/21 → 28/02/23
Project: Research

253780 Citations
229 h-index
2412 Article
470 Review article
169 Letter
166 Comment/debate
More

Large 22q13.3 deletions perturb peripheral transcriptomic and metabolomic profiles in Phelan-McDermid syndrome
the Developmental Synaptopathies Consortium, 12 Jan 2023, In: Human Genetics and Genomics Advances. 4, 1, 100145.
Research output: Contribution to journal › Article › peer-review

Open Access
Primary Antibody Immunodeficiency and the Pregnant Patient
Zhang, S. & Cunningham-Rundles, C., Feb 2023, In: Immunology and Allergy Clinics of North America. 43, 1, p. 133-144 12 p.
Research output: Contribution to journal › Review article › peer-review
17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
International Parkinson’s Disease Genomics Consortium (IPDGC), Dec 2022, In: Molecular Neurodegeneration. 17, 1, 48.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
ABCL-439 Subcutaneous Epcoritamab With Gemcitabine + Oxaliplatin (GemOx) Induced High Response Rates in Patients With Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Ineligible for Autologous Stem Cell Transplant (ASCT)
Brody, J., Wahlin, B. E., Phillips, T., Costello, R., Lugtenburg, P., Cordoba, R., Wang, L., Wu, J., Elliott, B., Abbas, A. & J⊘rgensen, J., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S379-S380
Research output: Contribution to journal › Article › peer-review
ABCL-452 First-Line Treatment With Subcutaneous Epcoritamab + R-CHOP in Patients With High-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Phase 1/2 Data Update
Falchi, L., Offner, F., Belada, D., Brody, J., Linton, K. M., Karimi, Y., Cordoba, R., Snauwaert, S., Abbas, A., Wang, L., Wu, J., Elliott, B. & Clausen, M. R., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S380
Research output: Contribution to journal › Article › peer-review
A Crowdsourcing Approach to Develop Machine Learning Models to Quantify Radiographic Joint Damage in Rheumatoid Arthritis
the RA2-DREAM Challenge Community, 2022, In: JAMA network open. 5, 8, e2227423.
Research output: Contribution to journal › Article › peer-review

Open Access
Advancing beyond the twists and turns of T cell exhaustion in cancer
van der Heide, V., Humblin, E., Vaidya, A. & Kamphorst, A. O., 9 Nov 2022, In: Science Translational Medicine. 14, 670, eabo4997.
Research output: Contribution to journal › Article › peer-review
Aging and IBD: A New Challenge for Clinicians and Researchers
Faye, A. S. & Colombel, J. F., 1 Jan 2022, In: Inflammatory Bowel Diseases. 28, 1, p. 126-132 7 p.
Research output: Contribution to journal › Article › peer-review
8 Scopus citations
Allergen immunotherapy and/or biologicals for IgE-mediated food allergy: A systematic review and meta-analysis
the GALEN Food Allergy Guidelines Group, Jun 2022, In: Allergy: European Journal of Allergy and Clinical Immunology. 77, 6, p. 1852-1862 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access

11 Scopus citations
Allergen recognition by specific effector Th2 cells enables IL-2-dependent activation of regulatory T-cell responses in humans
Lozano-Ojalvo, D., Tyler, S. R., Aranda, C. J., Wang, J., Sicherer, S., Sampson, H. A., Wood, R. A., Burks, A. W., Jones, S. M., Leung, D. Y. M., de Lafaille, M. C. & Berin, M. C., 2022, (Accepted/In press) In: Allergy: European Journal of Allergy and Clinical Immunology.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohorts
Berin, M. C., Agashe, C., Burks, A. W., Chiang, D., Davidson, W. F., Dawson, P., Grishin, A., Henning, A. K., Jones, S. M., Kim, E. H., Leung, D. Y. M., Masilamani, M., Scurlock, A. M., Sicherer, S. H., Wood, R. A. & Sampson, H. A., Apr 2022, In: Journal of Allergy and Clinical Immunology. 149, 4, p. 1373-1382.e12
Research output: Contribution to journal › Article › peer-review
7 Scopus citations
A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma
Zhou, R. W., Xu, J., Martin, T. C., Zachem, A. L., He, J., Ozturk, S., Demircioglu, D., Bansal, A., Trotta, A. P., Giotti, B., Gryder, B., Shen, Y., Wu, X., Carcamo, S., Bosch, K., Hopkins, B., Tsankov, A., Steinhagen, R., Jones, D. R., Asara, J., & 7 othersChipuk, J. E., Brody, R., Itzkowitz, S., Chio, I. I. C., Hasson, D., Bernstein, E. & Parsons, R. E., Dec 2022, In: Nature Communications. 13, 1, 6041.
Research output: Contribution to journal › Article › peer-review

Open Access

Targeting one immune cell type with another slows cancer growth
Brian Brown
1/11/22
1 item of Media coverage
Press/Media
What is the key factor in combating severe COVID in older adults?
Sacha Gnjatic
27/10/22
1 item of Media coverage
Press/Media
New approach to immunotherapy provokes a robust anti-tumor immune response in preclinical models
Brian Brown
26/10/22
1 item of Media coverage
Press/Media
Targeting one type of immune cell with another slows cancer growth in preclinical studies | Mount Sinai
Gurkan Mollaoglu, Brian Brown & Alessia Baccarini
25/10/22 → 26/10/22
9 items of Media coverage
Press/Media
Targeting 1 Type of Immune Cell with Another Slows Cancer Growth in Preclinical…
Gurkan Mollaoglu, Brian Brown & Alessia Baccarini
26/10/22
1 item of Media coverage
Press/Media
Mount Sinai Hospital: Targeting One Type Of Immune Cell With Another Slows Cancer Growth In Preclinical Studies
Gurkan Mollaoglu, Brian Brown & Alessia Baccarini
26/10/22
1 item of Media coverage
Press/Media
Targeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studies | Mount Sinai
Gurkan Mollaoglu, Brian Brown & Alessia Baccarini
26/10/22
1 item of Media coverage
Press/Media
Targeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studies
Gurkan Mollaoglu, Brian Brown & Alessia Baccarini
25/10/22
66 items of Media coverage
Press/Media
Icahn School of Medicine: Targeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studies
Gurkan Mollaoglu, Brian Brown & Alessia Baccarini
25/10/22
1 item of Media coverage
Press/Media
Targeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studies.
Gurkan Mollaoglu, Brian Brown & Alessia Baccarini
25/10/22
1 item of Media coverage
Press/Media
Using Insights from the Pandemic to Advance Research on Immunity in Down Syndrome
Dusan Bogunovic,
25/10/22
1 item of Media coverage
Press/Media
What Makes You at Risk for Alzheimer’s? Researchers Have New Insight
Jaroslav Bendl, Pengfei Dong, Jack Humphrey, Towfique Raj, Vahram Haroutunian, Panagiotis Roussos, Christopher Kellner,, John Fullard, Alexander Charney, Kiran Girdhar & Gabriel Hoffman
21/10/22 → 23/10/22
2 items of Media coverage
Press/Media